Patient-derived iPSCs faithfully represent the genetic diversity and cellular architecture of AML

Applying the syndemic framework to cancer research for effective cancer control in LMICs

Cetuximab with XELOX or XELIRI is tolerable and effective in RAS wild-type mCRC

Li-Fraumeni syndrome-associated dimer-forming mutant p53 promotes transactivation-independent mitochondrial cell death

Pegargiminase-pemetrexed-platinum triplet therapy prolongs survival in non-epithelioid pleural mesothelioma

Breast and emerging indications for IORT

The advantages of IORT for early breast cancer treatment

Choosing wisely in complementary treatment for cancer in the Philippines

Indications for the appropriate use of a PET-CT scan for common cancers

Choosing Wisely in neoadjuvant treatment for different cancers in the Philippines

Tackling financial toxicity in Chile

The role of CDK4/6 inhibitors in the treatment of metastatic breast cancer